Login / Signup

Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial.

Keith Y TeradaHyeong Jun AhnBruce Kessel
Published in: Journal of gynecologic oncology (2016)
These findings support the hypothesis that carcinogenic pathways for type 1 and type 2 ovarian cancer are different and distinct. The marked reduction in all ovarian cancer risk noted with a history of ectopic pregnancy and salpingectomy implies that the fallopian tube plays a key role in carcinogenesis for both type 1 and type 2 ovarian cancer.
Keyphrases
  • randomized controlled trial
  • squamous cell carcinoma
  • study protocol
  • preterm birth
  • double blind
  • pregnancy outcomes
  • placebo controlled